1. Home
  2. SQNS vs IKNA Comparison

SQNS vs IKNA Comparison

Compare SQNS & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQNS
  • IKNA
  • Stock Information
  • Founded
  • SQNS 2003
  • IKNA 2016
  • Country
  • SQNS France
  • IKNA United States
  • Employees
  • SQNS N/A
  • IKNA N/A
  • Industry
  • SQNS Semiconductors
  • IKNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SQNS Technology
  • IKNA Health Care
  • Exchange
  • SQNS Nasdaq
  • IKNA Nasdaq
  • Market Cap
  • SQNS 85.7M
  • IKNA 81.6M
  • IPO Year
  • SQNS 2011
  • IKNA 2021
  • Fundamental
  • Price
  • SQNS $2.70
  • IKNA $1.46
  • Analyst Decision
  • SQNS Strong Buy
  • IKNA Buy
  • Analyst Count
  • SQNS 1
  • IKNA 2
  • Target Price
  • SQNS $7.50
  • IKNA $3.00
  • AVG Volume (30 Days)
  • SQNS 105.2K
  • IKNA 171.8K
  • Earning Date
  • SQNS 02-11-2025
  • IKNA 03-11-2025
  • Dividend Yield
  • SQNS N/A
  • IKNA N/A
  • EPS Growth
  • SQNS N/A
  • IKNA N/A
  • EPS
  • SQNS 1.65
  • IKNA N/A
  • Revenue
  • SQNS $30,555,000.00
  • IKNA $659,000.00
  • Revenue This Year
  • SQNS $10.14
  • IKNA N/A
  • Revenue Next Year
  • SQNS $8.54
  • IKNA N/A
  • P/E Ratio
  • SQNS $1.83
  • IKNA N/A
  • Revenue Growth
  • SQNS N/A
  • IKNA N/A
  • 52 Week Low
  • SQNS $0.85
  • IKNA $1.22
  • 52 Week High
  • SQNS $7.33
  • IKNA $1.94
  • Technical
  • Relative Strength Index (RSI)
  • SQNS 37.19
  • IKNA 38.62
  • Support Level
  • SQNS $2.53
  • IKNA $1.40
  • Resistance Level
  • SQNS $3.39
  • IKNA $1.48
  • Average True Range (ATR)
  • SQNS 0.21
  • IKNA 0.05
  • MACD
  • SQNS -0.05
  • IKNA 0.00
  • Stochastic Oscillator
  • SQNS 19.16
  • IKNA 28.57

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

Share on Social Networks: